-
Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent
Tuesday, August 10, 2021 - 8:56am | 1191Read More...Cybin Debuts On The NYSE Last week, Cybin (NYSE: CYBN) began listing its stock on the New York Stock Exchange. The company is the first in the sector to enter the NYSE, following a trend of five psychedelics companies to debut on the Nasdaq since the beginning of the year. “This validation by...
-
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
Tuesday, August 3, 2021 - 2:23pm | 1810Read More...This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In just a couple of years, psychedelics took the world of investing by storm. What in 2019 was merely a buzzword for investors became a full-fledged industry boasting over 25...
-
2020 Was The Year of Psychedelics — Here's Why
Monday, December 28, 2020 - 10:02am | 1903Read More...While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics. There was unprecedented renaissance as psychedelic compounds, and their potential to treat mental health conditions, became one of the centerpieces of this year’s public...
-
Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia
Monday, December 14, 2020 - 11:09am | 892Read More...Canada Allows Professionals In Training To Use Psilocybin The Canadian Health Minister Patty Hajdu has allowed 17 healthcare professionals to possess and use psilocybin to conduct professional training in psilocybin-assisted therapy. The decision, announced Tuesday, marks the latest step in Canada...
